Rui Ling
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Breast Cancer Treatment Studies 12
- Cancer, Hypoxia, and Metabolism 7
- Cancer, Lipids, and Metabolism 3
- Oncology 11
- HER2/EGFR in Cancer Research 4
- Co-authors
- Jianghao Chen (9 shared papers)Jun Yun (7 shared papers)Juliang Zhang (7 shared papers)Hui Wang (5 shared papers)Ying Wu (7 shared papers)Zhe Wang (5 shared papers)Shifang Yuan (8 shared papers)Qing Yao (4 shared papers)
In The Last Decade
Rui Ling
67 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 408
- Molecular Biology 720
- Oncology 204
- Immunology 91
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by Rui Ling
This map shows the geographic impact of Rui Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ling more than expected).
Fields of papers citing papers by Rui Ling
This network shows the impact of papers produced by Rui Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ling. The network helps show where Rui Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Rui Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 116 | |
| 2 | 2022 | 100 | |
| 3 | 2006 | 91 | |
| 4 | 2023 | 69 | |
| 5 | 2014 | 64 | |
| 6 | 2018 | 64 | |
| 7 | 2019 | 64 | |
| 8 | 2022 | 59 | |
| 9 | 2015 | 56 | |
| 10 | 2004 | 54 | |
| 11 | 2017 | 47 | |
| 12 | 2017 | 45 | |
| 13 | 2013 | 43 | |
| 14 | 2014 | 42 | |
| 15 | 2021 | 36 | |
| 16 | 2013 | 27 | |
| 17 | 2024 | 24 | |
| 18 | 2020 | 23 | |
| 19 | Prognostic value of p53 alterations in human osteosarcoma: a meta analysis. | 2014 | 21 |
| 20 | 2024 | 18 |
About Rui Ling
Rui Ling is a scholar working on Cancer Research, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 68 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer-related gene regulation (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Chemical Sensor Technologies (3 papers), RNA modifications and cancer (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Cancer Research (408 citations), Molecular Biology (720 citations), Oncology (204 citations), Immunology (91 citations) and Pulmonary and Respiratory Medicine (123 citations). Rui Ling has collaborated with scholars based in China, Japan and Hong Kong. Frequent co-authors include Jianghao Chen, Jun Yun, Juliang Zhang, Hui Wang, Ying Wu, Zhe Wang, Shifang Yuan, Qing Yao, Lina Zhao and Xiaojun Li. Their work appears in journals such as Frontiers in Oncology, Talanta, Inflammation and Regeneration, Annals of Translational Medicine and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.